2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Nasdaq notified Roman DBDR Acquisition Corp. II on August 19, 2026, that it does not maintain the minimum of 400 holders required for continued listing. The notice has no immediate effect on the listing of the company's securities on the Nasdaq Global Market, but the company must submit a compliance plan, and failure to regain compliance could ultimately lead to delisting.
Nasdaq deficiency letter received August 19, 2026, under Listing Rule 5450(a)(2)
Compliance plan due to Nasdaq by October 5, 2026
If the plan is accepted, Nasdaq can grant an exception until February 15, 2027
If Nasdaq rejects the plan, the company may appeal to a Nasdaq Hearings Panel
SolarMax Technology received a Nasdaq notice on August 20, 2026, because it has not filed its Form 10-Q for the quarter ended June 30, 2026. The company has until October 19, 2026 to submit a plan to regain compliance, and Nasdaq could grant an exception to February 16, 2027 if it accepts that plan. The filing also discloses two earlier Nasdaq deficiencies, a bid price issue and a market value of listed securities issue, so shareholders face several open listing requirements at once.
Nasdaq notice dated August 20, 2026 cites Listing Rule 5250(c)(1) for the missing 10-Q for the quarter ended June 30, 2026
Plan to regain compliance due October 19, 2026; Nasdaq could allow an exception up to February 16, 2027 if the plan is accepted
Bid price deficiency notice received March 3, 2026; compliance deadline August 31, 2026; one-for-12 reverse stock split effected August 13, 2026
Market value of listed securities notice received June 22, 2026; compliance deadline December 21, 2026
Pasithea Therapeutics Corp. received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, moving the deadline from August 19, 2026 to February 16, 2027. The company says it may consider a reverse stock split, and if it does not regain compliance, Nasdaq could begin delisting proceedings, though the company says there is no assurance it will meet the new deadline.
Nasdaq letter dated February 20, 2026 flagged closing bid price below $1.00 for 30 consecutive business days.
Original compliance deadline was August 19, 2026; extension granted in an August 20, 2026 Nasdaq letter to February 16, 2027.
Company may consider a reverse stock split; if not compliant by the deadline, Nasdaq would issue a delisting notice that the company could appeal to a hearings panel.
Estrella Immunopharma received a Nasdaq notice on August 17, 2026, stating its common stock closed below $1.00 for 30 consecutive business days, so it no longer meets the minimum bid price requirement. The notice has no immediate effect on trading, and the company has until February 16, 2027 to regain compliance, which could involve a reverse stock split.
Nasdaq letter dated August 17, 2026 cites closing bid price below $1.00 from July 6, 2026 through August 14, 2026
Compliance period runs 180 calendar days, until February 16, 2027
Common stock continues to trade on The Nasdaq Capital Market under the symbol ESLA
If not compliant by the deadline, the company may be eligible for a second 180-day period, or face delisting notice and an appeal
JAB Acquisition Corp I entered a trademark settlement agreement on August 17, 2026, with a third party over its name and trading symbol, and reported it in an August 21, 2026 filing. Under the agreement, the company has asked Nasdaq to change its ticker and intends to rename itself Atlantic Acquisition Corp I, effective once its board and shareholders approve. The filing says current shareholders need take no action and that share ownership percentages and the capital structure are unaffected.
Settlement agreement dated August 17, 2026, with a third party identified as the Claimant
Company has requested a voluntary ticker change from Nasdaq; no effective date has been announced
Proposed new ticker symbols are listed as ATLQ, ATLQU, ATLQW and ATLQR, the same as the current symbol for the shares
Name change to Atlantic Acquisition Corp I requires board and shareholder approval; CIK number remains unchanged
Rain Enhancement Technologies Holdco received a Nasdaq notice on August 18, 2026 stating it had not regained compliance with the $35 million market value of listed securities requirement. Unless the company obtained a hearing, its shares would face suspension and delisting from the Nasdaq Capital Market on August 27, 2026. The company requested a hearing before the Nasdaq Hearings Panel on August 21, 2026, and expects this to stay any delisting action, but the filing says the panel may not grant continued listing.
Nasdaq notice received August 18, 2026 said the company had not regained compliance with the $35,000,000 MVLS threshold.
Compliance deadline was August 17, 2026, after a 180-calendar-day period that started with a February 18, 2026 notice.
Company requested a hearing before the Nasdaq Hearings Panel on August 21, 2026.
Scheduled suspension and delisting date is August 27, 2026, unless a stay applies; the company says there is no assurance the panel will grant continued listing.
loanDepot, Inc. (NYSE: LDI) received a written notice from the New York Stock Exchange on August 21, 2026, saying its Class A common stock failed the $1.00 minimum price standard because its average closing price was below $1.00 over 30 consecutive trading days. The company has six months to regain compliance, and if it cannot, the NYSE will begin procedures to suspend and delist the stock, which matters to shareholders because it sets a firm deadline for a share price recovery or a possible reverse stock split.
The NYSE notice was received August 21, 2026, and the company said the average closing price was below $1.00 as of August 20, 2026.
The company has a six-month cure period to bring its share price and average share price back to at least $1.00.
The company must notify the NYSE of its intent to cure within 10 business days of receiving the notice.
A reverse stock split is among the options the company will consider; it would need stockholder approval no later than the next annual meeting, anticipated for early June 2027.
Global Interactive Technologies (GITS) received a Nasdaq notice on August 20, 2026, because it did not timely file its Form 10-Q for the quarter ended June 30, 2026, which Nasdaq Listing Rule 5250(c)(1) requires for continued listing. The company says it expects to file the 10-Q promptly, and its common stock will remain listed and traded during the 60-day grace period.
Nasdaq notice received August 20, 2026, for not timely filing the Form 10-Q for the quarter ended June 30, 2026
Company has 60 calendar days from the notice date to submit a plan to regain compliance
If Nasdaq accepts the plan, an exception of up to 180 days from the 10-Q due date, or until February 16, 2027, is possible
Common stock continues to trade on Nasdaq during the grace period, subject to other listing requirements
Citius Pharmaceuticals received a Nasdaq extension until February 8, 2027 to show its stock closes at or above $1.00 per share, a continued listing requirement. The filing says the extension has no effect on the current listing, but if compliance is not regained by that date, Nasdaq will issue a delisting notice and the company may appeal.
Nasdaq granted an extension to February 8, 2027 for the $1.00 per share bid price requirement under Rule 5550(a)(2)
Compliance requires a closing bid of $1.00 or more for at least ten consecutive business days before February 8, 2027
Common stock will continue trading on the Nasdaq Capital Market under CTXR for now
The company says there can be no assurance it will regain compliance
Breeze Acquisition Corp. II received a Nasdaq notice on August 20, 2026, saying it no longer complies with listing rules because it has not filed its Form 10-Q reports for the quarters ended March 31 and June 30, 2026. The notice has no immediate effect on the listing or trading of the company's securities, but the company must submit a plan to regain compliance by September 21, 2026, and Nasdaq may grant an exception to December 28, 2026, with no assurance that this will happen.
Nasdaq notice received August 20, 2026, citing Listing Rule 5250(c)(1) for late periodic filings
Delinquent Form 10-Qs cover the periods ended March 31, 2026 and June 30, 2026
Compliance plan due September 21, 2026; Nasdaq may grant an exception until December 28, 2026 if the plan is accepted
Notice has no immediate effect on listing or trading; company says it does not assure compliance within the required period
VivoSim Labs (VIVS) received a Nasdaq notice on August 17, 2026 saying its stock no longer met the $1 minimum bid price over 30 consecutive business days. The company has 180 calendar days, until February 16, 2027, to regain compliance, and its shares continue to trade on the Nasdaq Capital Market for now. The company has proposed a reverse stock split, which requires stockholder approval, and a failure to regain compliance could lead to delisting proceedings.
Nasdaq notice received August 17, 2026 under Listing Rule 5550(a)(2) for the $1 minimum bid price
Compliance deadline is February 16, 2027; regaining it requires a closing bid of at least $1 for ten consecutive business days
Proposed reverse stock split ratio range of 1-for-5 to 1-for-20, subject to stockholder approval in the 2026 annual meeting proxy
Notice has no immediate effect on listing or trading; ticker remains VIVS
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.